Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results